Diagnosis & Early Detection/August 31, 2026/3 min read

A Hidden Connection: Why Children with Type 1 Diabetes May Need H. pylori Screening

A new study from Bulgaria found that children with Type 1 diabetes are twice as likely to carry Helicobacter pylori bacteria as their peers. Researchers say early detection could prevent serious complications later in life.

PubMed indexed literature

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

diagnosisscreeningautoantibodiesstaging

Key takeaways

Children with Type 1 diabetes in this study were twice as likely to test positive for H. pylori antibodies compared to children without diabetes
An even more striking difference emerged for CagA-positive strains—a more aggressive form of the bacteria that was three times more common in diabetic children
The connection between H. pylori and Type 1 diabetes remains unclear, but researchers suggest the bacteria may interfere with blood sugar control
This is observational research showing a link, not proof of cause-and-effect; larger studies are needed before screening becomes standard

What This Study Found

Researchers in Bulgaria tested 334 children—145 with Type 1 diabetes and 189 without—for antibodies to Helicobacter pylori, a bacterium that lives in the stomach. They found that 28.3% of children with Type 1 diabetes tested positive for H. pylori, compared to just 14.3% of the control group. That's roughly twice the rate.

An even more striking difference appeared when researchers looked specifically at CagA-positive strains, which produce a toxin that damages stomach cells. Nearly one-quarter (23.4%) of diabetic children carried this more aggressive form, versus only 8.5% of non-diabetic children—approximately three times higher.

Interestingly, the gap between diabetic and non-diabetic children widened with age. Among younger children (ages 1–6), the difference was smaller. But by ages 7–17, diabetic children were significantly more likely to test positive for both H. pylori and CagA.

Why This Matters

H. pylori infection is common worldwide but often causes no symptoms. However, if left untreated over time, it can lead to peptic ulcers and increase the risk of stomach cancer in adulthood. The question for people with Type 1 diabetes is whether this bacterial infection makes diabetes management harder.

The study authors note that H. pylori seropositivity 'may worsen both glycemic control and diabetes management'—meaning the infection could make blood sugar harder to control. If this link holds up in future research, early detection and treatment might protect both digestive health and metabolic health.

The researchers emphasize that confirming an active infection matters. A positive antibody test shows past or present exposure to the bacteria, but doesn't automatically mean someone is currently infected or needs treatment. That's why they call for more research before screening recommendations change.

What Comes Next

This study is observational—it shows a correlation between Type 1 diabetes and H. pylori seropositivity, but does not prove that one causes the other. Larger, prospective studies are needed to understand whether the bacteria actually worsens diabetes control, and whether treatment could help.

The researchers explicitly state that their findings 'support additional prospective research before screening recommendations are issued.' This means families and clinicians should not yet change their approach to H. pylori testing based on a Type 1 diabetes diagnosis alone.

If future research confirms a meaningful link, early identification of H. pylori in children with Type 1 diabetes could prevent serious complications—gastric ulcers, cancer risk, and potentially better blood sugar control—later in life.

Evidence label

Source: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.